Tatva Chintan Pharma Chem Limited Announces Board Meeting to Approve Q1 Financial Results

Vadodara, India, 16th July 2024 – Tatva Chintan Pharma Chem Limited has announced that a Board Meeting is scheduled to be held on Wednesday, 24th July 2024. The primary agenda of the meeting is to consider, approve, and take on record the standalone and consolidated unaudited financial results for the quarter ended 30th June 2024.

Details of the Announcement

In compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Tatva Chintan Pharma Chem Limited has informed both the BSE Limited and the National Stock Exchange of India Limited about the upcoming Board Meeting.

Key Points of the Announcement:

• Date and Time: Wednesday, 24th July 2024
• Location: Corporate Headquarters, Vadodara
• Agenda:
  • Consider and approve standalone unaudited financial results for the quarter ended 30th June 2024
  • Consider and approve consolidated unaudited financial results for the quarter ended 30th June 2024
• Trading Window Closure: The trading window has been closed from 1st July 2024 and will remain closed until 48 hours after the financial results are made public.

Compliance and Regulations

This notice is issued in accordance with Regulation 29 and other relevant provisions of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company ensures strict compliance with these regulations to maintain transparency and accountability.